A step by step demonstration of how we get the best candidates in just 21 days. Scroll your way through !
We first characterize your target: retrieve or model 3D structure, competitive analysis, suitable regions for antibody binding. Then we choose the epitope(s) with you.
We find antibodies binding to the chosen epitope. These antibodies can be designed completely in silico or they can come from different sources: your own antibody bank, MAbSilico’s antibody bank, NGS of enriched immune repertoires, NGS of patients repertoires.
The binders are optimized for affinity, developability, low off-targets number, diversity. The selected final candidates are your leads, ready for functional validations and pre-clinical studies.
Get antibodies binding to a determined region on your target
Get antibodies with nano-molar affinity
Get antibodies optimized and ready for pre-clinical developmement
MAbSilico enables our partners to accelerate and improve the success rate in identifying the best lead candidates. Our epitope-driven antibody design uses a multi-parameter approach to design antibodies while taking into account affinity, specificity, developability, and safety all at once.